What is the main business of Cardio Solutions?

The main business activity of Cardio Solutions focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 1, 2023.

Where is the headquarters located?

The headquarters is located at: 9E, 05-532 Szymanów.

Who is on the management board?

The management board consists of: Michał Sebastian Stańczyk (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of $51,984, representing a decrease of 5.9% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of $3,788, meaning the company decreased its profit by 41.6%.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $46,582 in 2025, representing 97% of all operating expenses.

Cardio Solutionssp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-03-01

Share capital

5,000.00 PLN

Registered address

9E, 05-532 Szymanów, Poland

Electronic delivery address

AE:PL-37370-61850-STHBH-32

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 59 days early.

202527/03/2026
202425/06/2025
202329/05/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 51.98kMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD 3.79kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 47.92kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 13.68kMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Barbara Janina Stańczyk – Attorney-in-fact

Michał Sebastian Stańczyk – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Barbara Janina Stańczykage 68	40	$540.25	40%
Michał Sebastian Stańczykage 43	60	$810.37	60%

Michał Sebastian Stańczyk and Barbara Janina Stańczyk hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2023-03-22.

PKO Bank Polski
23 1020 1026 0000 1602 0574 9025

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Biochem PolskaS.A.	$13,180,007.81	biochempolska.pl
PolypharmS.A.	$13,084,716.73	polypharm.pl
Surgical Solutionssp. z o.o.	$947,852.75	surgical-solutions.pl
MD International Medicalsp. z o.o.	$331,292.14	md-international.eu
Screenmedsp. z o.o.	$147,401.05	screenmed.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Jacek Frey i Wojciech FreyS.K.A.	–	frey.pl

FAQ

Last updated: 2026-03-27